A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
A Phase II Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
Sponsor: Alzheimer's Association
Listed as NCT01320527, this PHASE2 trial focuses on Alzheimer's Disease and Mild Cognitive Impairment and remains completed. Sponsored by Alzheimer's Association, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Aug 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alzheimer's Association
- University of Massachusetts, Lowell
- University of Massachusetts, Worcester
For direct contact, visit the study record on ClinicalTrials.gov .